Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 12, 2026 · Leadership change · Financial statements
BioRestorative Therapies, Inc.
7
Leadership change
Jun 12, 2026
| Item 5.02 | Director or executive officer departure or appointment |
| Item 9.01 | Financial statements and exhibits |
BioRestorative Therapies, Inc. filed this to disclose a change in directors or executive officers: appointments, departures, or role changes that can signal a strategic shift.
EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “ Agreement ”) is made as of June 10, 2026 (the “ Effective Date ”), by and between BioRestorative Therapies, Inc. , a Nevada corporation (the “ Company ”), and Francisco Silva (the “ Executive ”) (Company and Executive are collectively the “ Parties ”).
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
BioRestorative Therapies, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
